United Therapeutics (UTHR) Tops Q1 EPS by 32c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $542.60 +0.80%
EPS Growth %: +12.6%
Financial Fact:
Diluted (in shares): 46.2M
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: +12.6%
Financial Fact:
Diluted (in shares): 46.2M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $4.86, $0.32 better than the analyst estimate of $4.54. Revenue for the quarter came in at $506.9 million versus the consensus estimate of $512.69 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley upgrades CDW on stronger AI-driven server demand
- Piper Sandler on Fervo Energy (FRVO): 'Capital Access Supports Potential Upside'
- Goldman "broadly" raises estimates for LTL and truckload stocks
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
